Understand the source comparison
Quickcomparison
Dose Range Buserelin 200 mcg–1,500 mcg mcg Leuprolide 3.75 mg–45 mg monthly or 3-month injections (depending on formulation) Frequency Once daily Administration Subcutaneous injection Subcutaneous injection (daily) Cycle Length Ongoing/indefinite Onset Speed M
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dose Range
- Buserelin
- 200 mcg–1,500 mcg mcg
- Leuprolide
- 3.75 mg–45 mg monthly or 3-month injections (depending on formulation)
- Frequency
- Once daily
- Administration
- Subcutaneous injection
- Subcutaneous injection (daily)
- Cycle Length
- Ongoing/indefinite
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Strong human trials (Phase 3 or FDA approved)
- Efficacy